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Improved symptomatic, functional, and
fluoroscopic outcomes following serial
“series of three” double-balloon dilation for
cricopharyngeus muscle dysfunction
Derrick R. Randall1,2*, Lisa M. Evangelista1, Maggie A. Kuhn1 and Peter C. Belafsky1
Abstract
Background: Cricopharyngeus muscle dysfunction (CPMD) is a common cause of dysphagia. We employ a
progressive series of three double-balloon dilations separated by 4–6 weeks between procedures as a primary
treatment option. The purpose of this study was to evaluate subjective, functional and objective improvement in
swallowing after three serial dilations for CPMD.
Methods: We retrospectively evaluated patients between June 1, 2014, and June 30, 2016, who underwent a series
of three double-balloon dilations for CPMD. Pre- and post-dilation Eating Assessment Tool-10 (EAT-10), Functional
Oral Intake Scale (FOIS), pharyngeal constriction ratio, pharyngeal area, and pharyngoesophageal segment (PES)
opening were compared.
Results: Seventeen patients with CPMD underwent serial double-balloon dilation procedures separated by one
month. Mean age of the cohort was 73.5 (SD ± 13.3) years, and 53% were female. The mean EAT-10 improved from
24.7 (SD ± 7.8) to 15.9 (SD ± 10.2) [p = 0.0021]. Mean FOIS improved from 5.4 (SD ± 1.4) pre- to 6.3 (SD ± 0.9) post-
treatment (p = 0.017). Mean UES opening increased from 1.05 (SD ± 0.34) cm to 1.48 (SD ± 0.41) cm (p = 0.0003) in
the anteroposterior fluoroscopic view and from 0.58 (SD ± 0.18) to 0.76 (SD ± 0.30) cm (p = 0.018) in the lateral view.
Pharyngeal constriction ratio (PCR), a surrogate measure of pharyngeal strength, improved from 0.49 (SD ± 0.37) to
0.24 (SD ± 0.15) (p = 0.015), however pharyngeal area (PA) was unchanged.
Conclusions: A progressive series of three double-balloon dilations for cricopharyngeus muscle dysfunction resulted
in improved patient reported dysphagia symptom scores and objective fluoroscopic swallowing parameters.
Keywords: Dysphagia, Cricopharyngeus muscle dysfunction, Otolaryngology, Laryngology, Swallowing, Transnasal
esophagoscopy
Background
Oropharyngeal swallowing dysfunction is common and
costly. Complications include malnutrition, dehydration,
depression, social isolation, pneumonia, hospital admission,
increased length of stay, and death [1–3]. Early recognition
allows implementation of appropriate rehabilitation, diet
allocation or surgical management to prevent sequelae of
impairment [4–6]. The pharyngoesophageal segment (PES)
is a manometric high-pressure zone extending 3–5 cm
from the hypopharynx to the cervical esophagus. Dysphagia
resulting from PES dysfunction is a result of obstruction,
poor compliance, impaired laryngeal elevation or ineffective
pharyngeal propulsive forces [7]. Persons with PES dysfunc-
tion may present with solid food dysphagia, choking with
deglutition, throat clearing, and globus.
One of the most common causes of solid food oropha-
ryngeal dysphagia is cricopharyngeus muscle dysfunction
(CPMD) [8]. The cricopharyngeus muscle is an essential
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component of the PES and is responsible for preventing
the ingestion of air during respiration and reflux of
esophageal contents into the pharynx. CPMD manifests as
a spectrum of videofluoroscopic swallowing study (VFSS)
findings ranging from non-obstructing bars found in up to
30% of the asymptomatic population to severely obstruct-
ing bars that limit oral intake to solids and liquids (Fig. 1)
[9]. Pharyngeal constriction against an obstructed PES can
lead to the development of a dilated, weak pharynx and
Zenker’s diverticulum [10, 11]. Treatment options include
diet modification, botulinum toxin injection, dilation and
endoscopic or open myotomy [7]. A variety of procedural
interventions have been demonstrated to improve both
symptoms and radiographic evidence of CPMD [7, 12,
13]. The optimal treatment requires an individualized
strategy that takes into account disease severity, patient
comorbidities and functional status, prognosis and re-
quired duration of effect.
A recent systematic review of dilation for CPMD found
a variable response rate, ranging from 64 to 100% [12].
The variability in treatment efficacy may be related to dila-
tor size, number of procedures, and the underlying disease
process [14–17]. Furthermore, measures of swallowing
function can be assessed by one of the numerous dyspha-
gia symptom indices, if at all, or objective outcomes from
fluoroscopic investigations. In our center, we use a series
of progressively enlarging balloon dilations, utilizing two
balloons simultaneously to achieve a greater dilation pro-
file and better approximate the natural, kidney shape of
the PES [18, 19]. Patients are asked to complete Eating
Assessment Tool (EAT-10) and Functional Oral Intake
Scale (FOIS) instruments at all patient encounters in order
to measure their progress and assess the severity of their
symptoms. The EAT-10 has been validated for impact on
quality of life due to dysphagia for several different etiolo-
gies, while the FOIS evaluates the degree of oral diet cap-
acity by considering variety of consistencies a patient can
manage and the amount of enteral tube feeding required
[20, 21]. The purpose of this investigation was to deter-
mine the short term subjective and objective outcomes of
serial PES double-balloon dilation for CPMD.
Methods
Patient population and outcome measures
This investigation was approved by the University of
California, Davis Institutional Review Board (protocol
#905351–1). All patients with complete data who under-
went a series of three progressively increased balloon dila-
tions for CPMD between June 1, 2014, and June 30, 2016
were included. The diagnosis of CPMD was made on
VFSS. Patients who had undergone intervention for
CPMD prior to the VFSS and those with either Zenker
Fig. 1 Spectrum of cricopharyngeus muscle dysfunction showing asymptomatic narrowing of pharyngoesphageal segment to severe narrowing
and diverticulum formation. a Non-obstructing bar. b Moderately obstructing bar. c Severely obstructing bar. d Zenker’s diverticulum
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diverticulum or prior radiation therapy of the head and
neck were excluded. Pre- and post-dilation validated EAT-
10, FOIS, PES opening (cm) in the anteroposterior
(PESAP) and lateral (PESL) fluoroscopic view (Fig. 2),
pharyngeal constriction ratio (PCR), and pharyngeal area
(PA) were retrospectively collected.
Videofluoroscopic analysis
Fluoroscopic studies were performed according to our
center’s standard protocol [22, 23]. Each subject was ad-
ministered a bolus of liquid barium (EZ-PAQUE barium
sulfate suspension, 60% w/v; 41% w/w, E-Z-EM, Inc.,
Westbury, NY) in the following order: 1, 3, and 20 mL.
Each subject was also given a 3-cm3 bolus of barium
paste (EZpaste, E-Z-Em, Inc). Patients undergoing eso-
phagram did not receive a 3 mL bolus of liquid or paste
barium but did additionally receive a 13 mm barium tab-
let and large volume (> 60 mL) liquid barium trial via
straw drinking. The fluoroscopic studies were recorded
digitally with Olympus Image Stream Medical nStream
G3 HD/SD Video Recording (Image Stream Medical,
Littleton, MA) and were played back with WinDVD7 for
Windows (Intervideo, Corel Corp., Ottawa, Canada).
Objective fluoroscopic displacement measures were
obtained according to established protocols [9, 24–26].
In brief, pharyngeal area is measured in the lateral view
on the 1 mL liquid barium ‘hold’ position. The posterior
landmark starts superiorly at the posterior pharyngeal
wall anterior to the tubercle of the atlas and follows in-
feriorly to the floor of the hypopharynx. The anterior
boundary is traced from the posterior arytenoids to the
surface of the arytenoid cartilages, proceeds to the laryn-
geal surface of the epiglottis, curves into the valleculae,
then follows along the base of tongue. The anterior/su-
perior landmark ends at the velum. All measures requir-
ing lateral views utilize these landmarks. PCR is the ratio
of PA at maximal compression divided by the PA at rest
and is a validated measure of pharyngeal contractility.
An elevated PCR suggests diminished pharyngeal
strength [23]. Standardized measures of the PESL and
PESAP were obtained during the trial of 20 mL liquid
barium bolus. Anteroposterior (AP) measures for the
UES opening are obtained in the AP view with the same
superior and inferior landmarks; lateral boundaries are
defined as the maximal distention.
Surgical technique
All dilation procedures were performed under moni-
tored anesthesia care with sedation administered per
anesthesiologist preference. Typical sedation is achieved
with a combination of midazolam and fentanyl. Our
technique of dilation begins with the administration of a
combination xylocaine (4%) and neosynephrine (0.25%)
nasal spray administered 2–3 min prior to the proced-
ure. Flexible esophagoscopy is performed through the
more patent naris (Pentax VE-1530 transnasal esophago-
scope, Pentax Precision Medical Company, KayPentax,
Lincoln Park, NJ, USA). A diagnostic esophagoscopy is
performed and a guidewire(s) from a Hercules® 3 Stage
Wire Guided Balloon (Cook Medical, Bloomington, IN)
is inserted through the side channel of the endoscope.
The esophagoscope is then removed over the guide-
wire(s), replaced through the contralateral naris, and po-
sitioned in the hypopharynx to visualize the postcricoid
region. The dilation balloon(s) are then advanced over
the guidewire(s). Our protocol involves sequential
Fig. 2 Demonstration of pharyngoesophageal segment (PES) parameters in videofluoroscopy studies. a PES lateral view (PESL). b PES
anteroposterior view (PESAP). Measurement bars indicate narrowest opening dimension during 20 mL barium volume test
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dilation personalized for each patient but typically begins
with one 18–20 mm balloon in the first procedure,
followed by two 13–15 mm balloons in the second dila-
tion and two 15–18 mm balloons for the third dilation
(Fig. 3). Balloons were sequentially inflated through each
diameter and then held at final dilation for 60 s. After
deflation and removal, the PES was examined for signs
of injury to the mucosa. The mucosa is examined at
every stage of dilation and the procedure is terminated if
any blood is seen on the balloon or evidence of mucosal
laceration is visualized. The interval between dilations
was 4–8 weeks, dependent on patient and OR availabil-
ity, in accordance with use in prior studies [27, 28].
Statistical analysis
Statistical analysis was carried out using Stata 12.0 (Sta-
taCorp, College Way, TX), with descriptive statistics de-
termined for baseline and demographic data.
Comparison between pre- and post-dilation outcomes
was performed using paired t-tests for continuous vari-
ables and Wilcoxon matched pairs–signed rank test for
ordinal data. A Bonferroni correction was utilized to ad-
just for multiple comparisons.
Results
Seventeen patients with CPMD who underwent three
serial balloon dilations with complete pre- and post-
treatment fluoroscopy data were enrolled. The mean age
of the cohort was 73 (SD ± 11.5) years, 59% female.
Fifty-one dilations were done in total. The mean dur-
ation between pre- and post-treatment VFSS was 206
(SD ± 83) days and the mean time between final dilation
and post-treatment fluoroscopy was 37 (SD ± 33) days.
Median balloon dilator diameters for the first, second,
and third stages of the “series of three” dilations were
20 mm, 15 + 15 mm, and 18 + 18 mm, respectively, situ-
ated in the PES as shown in Fig. 3.
Changes in symptom and functional scores are dis-
played in Table 1. The mean EAT-10 improved from 24.
7 (SD ± 7.8) pre- to 15.9 (SD ± 10.2) post-treatment
(p = 0.0021). The mean FOIS improved from a mean of
5.4 (SD ± 1.4) pre- to 6.3 (SD ± 0.9) post-treatment (p =
0.017). In our series, individual patient EAT-10 and FOIS
scores either improved or were unchanged in 14/17 pa-
tients (82%) following the third dilation, compared to
pre-treatment values.
Changes in radiographic outcome are displayed in
Table 2. PESAP increased from 1.05 cm (SD ± 0.34 cm) to
1.48 cm (SD ± 0.41 cm) (p = 0.0003). PESL increased from
0.58 cm (SD ± 1.8 cm) to 0.76 cm (SD ± 0.30 cm) (p = 0.
018). These values represent increases in PES opening
width and anteroposterior space of 41 and 31%, respect-
ively (Fig. 4). Among patients with severely obstructed
CPMD (PESL opening less than 0.5 cm, n = 7) the antero-
posterior opening increased by 72% from 0.39 cm (SD ± 0.
07 cm) to 0.67 cm (SD ± 0.27 cm) (p = 0.047). Patients
who underwent serial balloon dilation also showed im-
provement in PCR from 0.49 (SD ± 0.37) to 0.23 (SD ± 0.
15) (p = 0.015), indicating improved ability to constrict the
pharynx and propel a food bolus through the PES. Despite
improved constriction, PA showed no difference between
pre- and post-treatment values (p = 0.91). There were no
perforations of the upper esophagus or PES identified in
this study cohort, and no patients developed delayed in-
fections in the neck.
To evaluate the durability of our treatment approach,
we reviewed patient records to determine whether mem-
bers of our cohort underwent additional treatments. We
identified ten patients (59%) who underwent additional
upper esophageal procedures, nine of whom had repeat
dilations and one who opted for a cricopharyngeus
myotomy. The mean duration of time between the third
dilation and a repeat procedure was 416 days (SD ± 246,
range = 124–849 days). Five patients who underwent
subsequent treatments also had fluoroscopic studies re-
peated, however there were no statistically significant
differences between the measures obtained after the
third dilation and the later dilation. Similarly, there were
Fig. 3 Transnasal esophagoscope view of pharynx during sequential balloon dilation using a) one and b) two balloon dilators.
CPM = cricopharyngeus muscle
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no differences between EAT-10 or FOIS scores (n = 9)
following additional treatments.
Discussion
In this study, we investigated the effect of serial PES dila-
tion for CPMD and report improved patient-reported
symptoms, functional, and fluoroscopic short-term out-
comes. We observed marked improvements in PES open-
ing and EAT-10 scores, confirming existing data that PES
dilation is an effective method to address CPMD [12].
Though symptom scores do not return to normal after
intervention, they suggest significant improvement, which
is compatible with measured fluoroscopic outcomes.
Our study provides several interesting findings related
to the efficacy of serial double-balloon dilation to a size
larger than what can be achieved with a single balloon. As
expected, both PESAP and PESL opening increase in these
patients but the increase is more pronounced in the anter-
ior posterior projection (PESAP). The fluoroscopic finding
of a hypertrophic cricopharyngeus muscle used to diag-
nose CPMD is typically identified on the lateral VFSS pro-
jection. We did not expect the greatest therapeutic benefit
to be appreciated in the anteriorposterior fluoroscopic
view (PESAP). Previous fluoroscopic data report improve-
ment in the lateral fluoroscopic view only (PESL) [10, 16].
Fig. 3 illustrates that the increased dilation obtained by
using two balloons occurs in a vector that should increase
the lateral dimension of the PES, a consequence that
would result in improved opening on the AP VFSS. This
degree of lateral expansion cannot be effectively achieved
with a single, circular balloon or bougie.
Anectodal experience and case reports indicate reflux
symptoms can worsen following cricopharyngeus myotomy
in select populations [29–31], leading some authors to con-
sider reflux or ineffective esophageal motility a contraindica-
tion [32]. However, manometric studies of PES pressures
before and after cricopharyngeus muscle myotomy demon-
strate reduction of resting pressure to normal values with no
increase in pharyngeal acid regurgitation [33–35]. The crico-
pharyngeus muscle is not ablated or resected with dilation,
and it has been reported that single balloon dilation reduces
the size of an obstructing cricopharyngeus muscle less than
myotomy [10]. We observed persistent fluoroscopic indenta-
tion of the PES in most patients post serial dilations. This
suggests that serial dilation may cause less diminution to the
protective function of the PES than myotomy.
Another interesting observation was the disparate change
in PCR and PA following serial PES dilation. While
pharyngeal contraction improved (PCR), the pharynx
remained dilated (PA). These data are consistent with other
reports after both dilation and myotomy [10], which sug-
gests that some of the pharyngeal dilation caused by pro-
longed PES obstruction may be permanent. A dilated
pharynx is associated with decreased pharyngeal contractil-
ity and resting tone and is a major risk factor for aspiration.
The finding that some of the pharyngeal insult caused by
the CPMD is permanent may support earlier intervention
before end stage pharyngeal dilation occurs. This is similar
to findings in esophageal achalasia, which support LES
intervention before the development of an atonic, dilated,
sigmoid esophagus [36, 37].
This investigation is not without limitations. Definitive
conclusions cannot be drawn from this retrospective case
series. As with all musculotendinous injuries, return to
function and rehabilitation is generally measured in months
rather than days or weeks [38], which exceeds the mean
duration between the final dilation and fluoroscopic assess-
ment of 37 days. Thus, it is possible that the maximum
amount of improvement was not captured. In addition, we
were not able to determine improvements between dilation
procedures, so it is not known at what point patients expe-
rienced the greatest improvement. Our clinical experience
suggests that a series of three double-balloon dilations with
a gradual increase in balloon diameter provides the safest
most effective treatment strategy. Previous investigation has
reported lateral fluoroscopic PES opening improvement to
0.62 cm after single balloon dilation and 0.82 cm after
myotomy [10]. While the improvement to 0.76 cm reported
in this investigation suggests that a series of three sequen-
tial dilations provides improved outcomes over a traditional
single balloon procedure, a randomized prospective com-
parison is required before definitive improvement can be
confirmed. This may prove difficult, as dilation is often re-
served for elderly persons with significant medical comor-
bidity and myotomy recommended for younger, healthier
Table 1 Pre-and post-treatment symptom scale and functional
outcome measures
Parameter n Pre-treatment
(+/− SD)
Post-treatment
(+/− SD)
p value
EAT-10 17 24.7 (7.8) 15.9 (10.2) 0.0021*
FOIS 17 5.4 (1.5) 6.3 (0.9) 0.017**
EAT-10 eating assessment tool, FOIS functional oral intake scale
*Paired t-test
**Wilcoxon matched pairs–signed rank test
Table 2 Pre-and post-treatment VFSS outcome measures. All
tests performed with paired t-tests
Parameter n Pre-treatment
(+/− SD)
Post-treatment
(+/− SD)
p value
PESAP opening (cm) 15 1.05 (0.34) 1.48 (0.41) 0.0003
PESL opening (cm) 17 0.58 (0.18) 0.76 (0.30) 0.018
Pharyngeal
constriction ratio
13 0.49 (0.37) 0.24 (0.15) 0.015
Pharyngeal area (cm2) 12 9.45 (3.62) 9.52 (3.96) 0.91
PESAP upper esophageal sphincter in anterior-posterior view, PESL upper
esophageal opening in lateral view
Randall et al. Journal of Otolaryngology - Head and Neck Surgery  (2018) 47:35 Page 5 of 8
individuals. This study was limited to persons with
complete survey (EAT-10) and fluoroscopic data after three
procedures. Individuals who experienced significant im-
provement after one or two dilations were excluded, as
were individuals who were lost to follow-up or declined a
postoperative fluoroscopic swallow study. The influence of
this follow-up bias has an uncertain effect on the improve-
ment reported in this investigation.
This investigation was designed to determine the short-
term symptomatic and objective outcomes of a series of
three PES dilations. Previous investigations suggest there
is inadequate long-term response following dilation to
20 mm, particularly among persons with CPMD second-
ary to neurodegenerative disease such as oculopharyngeal
muscular dystrophy [7, 39]. Ideally serial dilation would
provide longer duration of benefit. We do not have pa-
tients routinely return for reassessment unless their symp-
toms recur, but our clinical experience with this technique
suggests some patients develop symptomatic recurrence
with less severe degree of cricopharyngeus muscle ob-
struction that responds to a single repeat treatment. We
reviewed our cohort and found there was a subset of pa-
tients who returned for additional treatments. In this rela-
tively small series, 59% of patients needed treatment again
at a later date, on average 416 days after the third dilation.
This is congruent with reported rates and timing of recur-
rence of swallowing dysfunction following dilation of the
cricopharyngeus, but the heterogeneity of the data in-
cluded in these studies makes direct comparison of any in-
dividual techniques difficult [7, 12, 39]. Indeed, recurrence
and durability are important considerations in the man-
agement of CPMD and appropriate patient counseling, so
rigorous future prospective investigation to properly ad-
dress this question are needed. Defining recurrence based
on either symptoms or objective data is challenging and
varies between patients, so our study advances under-
standing in what outcomes can be expected.
Though serial double-balloon dilation is performed at nu-
merous centers, there is little literature on its safety. The
key complication or side effect of concern in these proce-
dures is upper esophageal perforation. During the study
period we did not have any perforations of the upper aero-
digestive tract. Presumably the risk of perforation is in-
creased with greater dilation diameter. Mucosal lacerations
occurred in some instances, but this was not discretely re-
corded and could not be measured. In our experience, a
simple mucosal laceration did not lead to any instances of
deep neck space infections or other complications. Al-
though we believe progressive dilation over three serial en-
counters with appropriate recovery intervals reduces the
likelihood of this complication, further investigation is re-
quired to confirm this assertion. Optimal interval between
dilations is debatable, with repeat dilations for benign mu-
cosal strictures of the esophagus often done in weekly inter-
vals, but we believe CPMD treatment allows longer
intervals between treatments without losing efficacy, given
the apparent average duration of effect [12, 27, 28, 40]. Even
with the inherent limitations of this retrospective case
series, the data suggest that a “series of three” dilation ap-
proach is a safe and effective treatment of cricopharyngeus
muscle dysfunction and support the need for further study.
Conclusion
Our data suggest a “series of three” serial balloon dilation is a
safe and effective treatment for CPMD. The treatment re-
sults in a significant improvement in symptomatic dysphagia
(EAT-10), functional oral intake (FOIS), and objective fluoro-
scopic parameters. Further investigation is required to evalu-
ate the durability and compare outcomes of this approach to
traditional techniques of single balloon PES dilation.
Fig. 4 Mean values of pre- and post-dilation opening dimensions of the pharyngoesphageal segment (PES). AP = anteroposterior view
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